nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—Melatonin—MPO—periodontitis	0.0537	1	CrCbGaD
Rizatriptan—HTR1F—Monoamine GPCRs—ADRB1—periodontitis	0.04	0.0423	CbGpPWpGaD
Rizatriptan—HTR1F—Amine ligand-binding receptors—ADRB1—periodontitis	0.0336	0.0355	CbGpPWpGaD
Rizatriptan—HTR1D—Monoamine GPCRs—ADRB1—periodontitis	0.0256	0.027	CbGpPWpGaD
Rizatriptan—HTR1B—Monoamine GPCRs—ADRB1—periodontitis	0.025	0.0265	CbGpPWpGaD
Rizatriptan—MAOA—Melatonin metabolism and effects—ADRB1—periodontitis	0.0249	0.0263	CbGpPWpGaD
Rizatriptan—HTR1F—GPCRs, Other—CXCR2—periodontitis	0.0229	0.0242	CbGpPWpGaD
Rizatriptan—HTR1D—Amine ligand-binding receptors—ADRB1—periodontitis	0.0215	0.0227	CbGpPWpGaD
Rizatriptan—HTR1B—Amine ligand-binding receptors—ADRB1—periodontitis	0.021	0.0222	CbGpPWpGaD
Rizatriptan—MAOA—Serotonin Transporter Activity—IL1B—periodontitis	0.0203	0.0214	CbGpPWpGaD
Rizatriptan—HTR1A—Monoamine GPCRs—ADRB1—periodontitis	0.0191	0.0202	CbGpPWpGaD
Rizatriptan—HTR1F—G alpha (i) signalling events—CXCL3—periodontitis	0.0167	0.0176	CbGpPWpGaD
Rizatriptan—HTR1A—Amine ligand-binding receptors—ADRB1—periodontitis	0.016	0.0169	CbGpPWpGaD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.0133	0.014	CbGpPWpGaD
Rizatriptan—CYP1A2—Aflatoxin activation and detoxification—GGT1—periodontitis	0.0112	0.0118	CbGpPWpGaD
Rizatriptan—CYP1A2—Estrogen Receptor Pathway—PPARA—periodontitis	0.0108	0.0114	CbGpPWpGaD
Rizatriptan—HTR1F—G alpha (i) signalling events—CXCR2—periodontitis	0.0107	0.0113	CbGpPWpGaD
Rizatriptan—HTR1D—G alpha (i) signalling events—CXCL3—periodontitis	0.0107	0.0113	CbGpPWpGaD
Rizatriptan—HTR1B—G alpha (i) signalling events—CXCL3—periodontitis	0.0104	0.011	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—CXCL3—periodontitis	0.0101	0.0107	CbGpPWpGaD
Rizatriptan—HTR1F—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00997	0.0105	CbGpPWpGaD
Rizatriptan—CYP1A2—Melatonin metabolism and effects—ADRB1—periodontitis	0.00918	0.0097	CbGpPWpGaD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00854	0.00902	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.00847	0.00896	CbGpPWpGaD
Rizatriptan—HTR1F—G alpha (i) signalling events—CCR2—periodontitis	0.00835	0.00883	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.0083	0.00877	CbGpPWpGaD
Rizatriptan—HTR1A—G alpha (i) signalling events—CXCL3—periodontitis	0.00795	0.0084	CbGpPWpGaD
Rizatriptan—HTR1F—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00775	0.00819	CbGpPWpGaD
Rizatriptan—HTR1F—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00772	0.00815	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—IL13—periodontitis	0.00741	0.00783	CbGpPWpGaD
Rizatriptan—HTR1D—G alpha (i) signalling events—CXCR2—periodontitis	0.00687	0.00726	CbGpPWpGaD
Rizatriptan—HTR1B—G alpha (i) signalling events—CXCR2—periodontitis	0.00673	0.00711	CbGpPWpGaD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00664	0.00702	CbGpPWpGaD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00661	0.00699	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—CXCR2—periodontitis	0.0065	0.00687	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—IL1RN—periodontitis	0.00648	0.00684	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—CXCL3—periodontitis	0.00645	0.00682	CbGpPWpGaD
Rizatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00637	0.00674	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.00632	0.00668	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—CXCL3—periodontitis	0.00632	0.00668	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—IL13—periodontitis	0.0063	0.00666	CbGpPWpGaD
Rizatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00624	0.0066	CbGpPWpGaD
Rizatriptan—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—periodontitis	0.00594	0.00628	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—CXCL3—periodontitis	0.0057	0.00603	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—IL1RN—periodontitis	0.00551	0.00582	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00546	0.00577	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00535	0.00565	CbGpPWpGaD
Rizatriptan—HTR1D—G alpha (i) signalling events—CCR2—periodontitis	0.00534	0.00564	CbGpPWpGaD
Rizatriptan—HTR1B—G alpha (i) signalling events—CCR2—periodontitis	0.00523	0.00553	CbGpPWpGaD
Rizatriptan—MAOA—Biological oxidations—GGT1—periodontitis	0.00519	0.00549	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—CXCL3—periodontitis	0.00518	0.00547	CbGpPWpGaD
Rizatriptan—CYP1A2—Arachidonic acid metabolism—GGT1—periodontitis	0.00515	0.00544	CbGpPWpGaD
Rizatriptan—HTR1A—G alpha (i) signalling events—CXCR2—periodontitis	0.00512	0.00541	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—CCR2—periodontitis	0.00506	0.00534	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—ADRB1—periodontitis	0.00503	0.00532	CbGpPWpGaD
Rizatriptan—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—periodontitis	0.00501	0.0053	CbGpPWpGaD
Rizatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00496	0.00524	CbGpPWpGaD
Rizatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00493	0.00521	CbGpPWpGaD
Rizatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00485	0.00513	CbGpPWpGaD
Rizatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00483	0.00511	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—CXCL3—periodontitis	0.00481	0.00509	CbGpPWpGaD
Rizatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00475	0.00502	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—IL1A—periodontitis	0.00466	0.00493	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—IL10—periodontitis	0.00463	0.0049	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00425	0.00449	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00423	0.00447	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—CXCR2—periodontitis	0.00416	0.00439	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00416	0.00439	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00414	0.00437	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—VIP—periodontitis	0.00412	0.00436	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00407	0.0043	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—CXCR2—periodontitis	0.00407	0.0043	CbGpPWpGaD
Rizatriptan—HTR1A—G alpha (i) signalling events—CCR2—periodontitis	0.00398	0.00421	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—IL1A—periodontitis	0.00396	0.00419	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—IL10—periodontitis	0.00394	0.00416	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—VIP—periodontitis	0.00374	0.00396	CbGpPWpGaD
Rizatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.0037	0.00391	CbGpPWpGaD
Rizatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00368	0.00389	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—CXCR2—periodontitis	0.00367	0.00388	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—CXCL3—periodontitis	0.00365	0.00385	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—CXCL3—periodontitis	0.00357	0.00377	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—CXCR2—periodontitis	0.00334	0.00353	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CXCL3—periodontitis	0.00331	0.0035	CbGpPWpGaD
Rizatriptan—CYP1A2—Phase II conjugation—GGT1—periodontitis	0.00327	0.00346	CbGpPWpGaD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00327	0.00346	CbGpPWpGaD
Rizatriptan—HTR1F—G alpha (i) signalling events—CXCL8—periodontitis	0.00325	0.00344	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CXCL3—periodontitis	0.00324	0.00343	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—CCR2—periodontitis	0.00323	0.00342	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—ADRB1—periodontitis	0.00322	0.0034	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00317	0.00335	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—CCR2—periodontitis	0.00317	0.00335	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00315	0.00333	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—ADRB1—periodontitis	0.00315	0.00333	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—CXCR2—periodontitis	0.0031	0.00328	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CXCL3—periodontitis	0.00306	0.00323	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—CCR2—periodontitis	0.00286	0.00302	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—ADRB1—periodontitis	0.00285	0.00301	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CXCL3—periodontitis	0.00272	0.00287	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—SLC52A3—periodontitis	0.00271	0.00286	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—periodontitis	0.00267	0.00282	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—VIP—periodontitis	0.00264	0.00279	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—CCR2—periodontitis	0.0026	0.00274	CbGpPWpGaD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00259	0.00273	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—ADRB1—periodontitis	0.00258	0.00273	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—VIP—periodontitis	0.00258	0.00273	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—periodontitis	0.00256	0.00271	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—CXCL8—periodontitis	0.00253	0.00268	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—CCL2—periodontitis	0.00249	0.00263	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CXCL3—periodontitis	0.00247	0.00261	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—IL1B—periodontitis	0.00243	0.00257	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—CCR2—periodontitis	0.00241	0.00255	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—ADRB1—periodontitis	0.0024	0.00254	CbGpPWpGaD
Rizatriptan—CYP1A2—Arachidonic acid metabolism—PTGS2—periodontitis	0.00239	0.00253	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—VIP—periodontitis	0.00239	0.00253	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—periodontitis	0.00238	0.00252	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—CXCR2—periodontitis	0.00235	0.00248	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—VIP—periodontitis	0.00234	0.00248	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—CXCR2—periodontitis	0.0023	0.00243	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—VIP—periodontitis	0.00221	0.00234	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—CXCL8—periodontitis	0.00215	0.00228	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CXCR2—periodontitis	0.00213	0.00226	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00209	0.00221	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CXCR2—periodontitis	0.00209	0.00221	CbGpPWpGaD
Rizatriptan—HTR1D—G alpha (i) signalling events—CXCL8—periodontitis	0.00208	0.0022	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—IL1B—periodontitis	0.00207	0.00218	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00205	0.00217	CbGpPWpGaD
Rizatriptan—HTR1B—G alpha (i) signalling events—CXCL8—periodontitis	0.00204	0.00215	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CXCR2—periodontitis	0.00197	0.00208	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—CXCL8—periodontitis	0.00197	0.00208	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—MMP3—periodontitis	0.00197	0.00208	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—VIP—periodontitis	0.00197	0.00208	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CXCL3—periodontitis	0.00196	0.00207	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CXCL3—periodontitis	0.00192	0.00202	CbGpPWpGaD
Rizatriptan—CYP1A2—Biological oxidations—GGT1—periodontitis	0.00192	0.00202	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—periodontitis	0.00185	0.00196	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—CCR2—periodontitis	0.00183	0.00193	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—ADRB1—periodontitis	0.00182	0.00192	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—CCR2—periodontitis	0.00179	0.00189	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—VIP—periodontitis	0.00179	0.00189	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—ADRB1—periodontitis	0.00178	0.00188	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—TNF—periodontitis	0.00176	0.00186	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CXCR2—periodontitis	0.00175	0.00185	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—periodontitis	0.00173	0.00183	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—periodontitis	0.00173	0.00183	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CCR2—periodontitis	0.00166	0.00175	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00165	0.00175	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—ADRB1—periodontitis	0.00165	0.00175	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CCR2—periodontitis	0.00163	0.00172	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00162	0.00171	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—ADRB1—periodontitis	0.00162	0.00171	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ACP5—periodontitis	0.0016	0.00169	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—CCL2—periodontitis	0.00159	0.00168	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CXCR2—periodontitis	0.00159	0.00168	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00156	0.00165	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—CCL2—periodontitis	0.00156	0.00165	CbGpPWpGaD
Rizatriptan—HTR1A—G alpha (i) signalling events—CXCL8—periodontitis	0.00155	0.00164	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CCR2—periodontitis	0.00153	0.00162	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—ADRB1—periodontitis	0.00153	0.00161	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—TNF—periodontitis	0.0015	0.00158	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CXCL3—periodontitis	0.00146	0.00154	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—IL6—periodontitis	0.00142	0.0015	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—VIP—periodontitis	0.00141	0.00149	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—VIP—periodontitis	0.00138	0.00146	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CCR2—periodontitis	0.00136	0.00144	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—ADRB1—periodontitis	0.00136	0.00143	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—CCL2—periodontitis	0.00128	0.00135	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CXCR2—periodontitis	0.00126	0.00133	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—CXCL8—periodontitis	0.00126	0.00133	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—MMP3—periodontitis	0.00126	0.00133	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NTRK1—periodontitis	0.00125	0.00132	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CCR2—periodontitis	0.00124	0.00131	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CXCR2—periodontitis	0.00123	0.0013	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00123	0.0013	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—CXCL8—periodontitis	0.00123	0.0013	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—ADRB1—periodontitis	0.00123	0.0013	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—MMP3—periodontitis	0.00123	0.0013	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—IL6—periodontitis	0.00121	0.00128	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—CCL2—periodontitis	0.00119	0.00126	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MMP3—periodontitis	0.00116	0.00123	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—CXCL8—periodontitis	0.00111	0.00118	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—VIP—periodontitis	0.00106	0.00111	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—CXCL8—periodontitis	0.00101	0.00107	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SLC52A3—periodontitis	0.000999	0.00106	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCR2—periodontitis	0.00098	0.00104	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ADRB1—periodontitis	0.000976	0.00103	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCR2—periodontitis	0.00096	0.00101	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ADRB1—periodontitis	0.000956	0.00101	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CXCR2—periodontitis	0.00094	0.000994	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—CXCL8—periodontitis	0.00094	0.000993	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—MMP3—periodontitis	0.000938	0.000991	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GGT1—periodontitis	0.000888	0.000938	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CCL2—periodontitis	0.000818	0.000864	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CCL2—periodontitis	0.000801	0.000846	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NTRK1—periodontitis	0.000799	0.000845	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NTRK1—periodontitis	0.000783	0.000827	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CCL2—periodontitis	0.000755	0.000798	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MMP3—periodontitis	0.000743	0.000785	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000735	0.000777	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCR2—periodontitis	0.000731	0.000773	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ADRB1—periodontitis	0.000728	0.000769	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MMP3—periodontitis	0.000728	0.000769	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—CXCL8—periodontitis	0.000712	0.000752	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—CXCL8—periodontitis	0.000697	0.000737	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—FGF2—periodontitis	0.000683	0.000721	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CXCL8—periodontitis	0.000647	0.000683	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PPARA—periodontitis	0.000636	0.000672	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CXCL8—periodontitis	0.000633	0.000669	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CCL2—periodontitis	0.00061	0.000645	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CXCL8—periodontitis	0.000597	0.000631	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NTRK1—periodontitis	0.000596	0.00063	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ACP5—periodontitis	0.000589	0.000622	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—IL6—periodontitis	0.000568	0.0006	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MMP3—periodontitis	0.000554	0.000586	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MMP9—periodontitis	0.00054	0.000571	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CXCL8—periodontitis	0.000531	0.000561	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000526	0.000556	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCL2—periodontitis	0.000483	0.000511	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CXCL8—periodontitis	0.000482	0.00051	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCL2—periodontitis	0.000473	0.0005	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TGFB1—periodontitis	0.000445	0.00047	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FGF2—periodontitis	0.000437	0.000461	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FGF2—periodontitis	0.000428	0.000452	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTGS2—periodontitis	0.000413	0.000437	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CXCL8—periodontitis	0.000382	0.000404	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CXCL8—periodontitis	0.000374	0.000395	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—IL6—periodontitis	0.000363	0.000384	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCL2—periodontitis	0.00036	0.000381	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—IL6—periodontitis	0.000356	0.000376	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MMP9—periodontitis	0.000345	0.000365	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.000342	0.000362	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MMP9—periodontitis	0.000338	0.000357	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IL6—periodontitis	0.000336	0.000355	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GGT1—periodontitis	0.000328	0.000346	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FGF2—periodontitis	0.000326	0.000344	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CXCL8—periodontitis	0.000285	0.000301	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TGFB1—periodontitis	0.000285	0.000301	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TGFB1—periodontitis	0.000279	0.000295	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL6—periodontitis	0.000271	0.000286	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MMP9—periodontitis	0.000258	0.000272	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PPARA—periodontitis	0.000234	0.000248	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL6—periodontitis	0.000215	0.000227	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TGFB1—periodontitis	0.000212	0.000224	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL6—periodontitis	0.00021	0.000222	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL6—periodontitis	0.00016	0.000169	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTGS2—periodontitis	0.000152	0.000161	CbGpPWpGaD
